Tumour Seeding with Needle Biopsy of Hepatocellular Carcinoma—A Systematic Review

Chunpeng Nie,Marcus Vaska,Jason K. Wong,Oliver F. Bathe,Stefan Przybojewski,Kelly W. Burak,Patricia A. Tang,Stephen E. Congly
DOI: https://doi.org/10.14309/ajg.0000000000003210
2024-11-24
The American Journal of Gastroenterology
Abstract:INTRODUCTION: Biopsy of hepatocellular carcinoma (HCC) may help with selecting appropriate chemotherapy with inconclusive imaging; concern about potential seeding may limit its use. METHODS: A systematic review was conducted to assess the risk of tumour seeding with biopsy of HCC excluding non-liver cancers or seeding after interventions. RESULTS: 2339 unique abstracts were identified; 37 studies were included in the final analysis. The rate of tumour seeding was 0.62% (range 0-7.77%) in 13,959 biopsies performed. The average reported median lengths of follow-up was 35.8 months (range 10.5-60 months). DISCUSSION: Overall, the risk of tumour seeding with biopsy of HCC is low.
gastroenterology & hepatology
What problem does this paper attempt to address?